Precision radiation for difficult brain tumors from lung cancer
Part of Brain & nervous system, Cancer clinical trials.
This study tests a precise, targeted radiation technique for people with lung cancer that has spread to the brain. It aims to treat these brain tumors effectively while limiting harm to healthy tissue, which may help control the cancer and maintain quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with lung cancer (non-small cell or small cell).
- You have one to three brain tumors that are at least 2 cm (about 1 inch) across, confirmed by an MRI scan.
- You have not had radiation therapy to the brain before.
- You are generally able to take care of yourself (Karnofsky score of at least 60, or at least 40 if the only issue is the brain tumors).
- You can lie flat for more than 45 minutes and can undergo MRI scans.
- You must be willing to provide tissue samples from your tumor for testing.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at whether the timing of radiation therapy and immunotherapy (like Keytruda or Opdivo) affects outcomes in patients with non-small cell lung cancer (NSCLC) that has spread to the brain. You would receive both treatments as part of your normal care, and the study will track how you do.
This trial tests a new way to deliver radiation to brain metastases from non-small cell lung cancer, using MRI scans to guide the treatment and reduce the area exposed. The goal is to see if this approach is safe and effective while possibly lowering side effects.
This study tests a new way to plan and deliver radiation therapy for glioblastoma (an aggressive brain tumor) using special MRI scans to target cancer cells more precisely. The goal is to improve treatment effectiveness while reducing harm to healthy brain tissue.
This trial tests giving targeted radiation while surgeons are operating to treat brain metastases. It may help control the cancer locally at the time of surgery, especially for certain single lesions.
This Phase 2 study tests a precise, no-head-frame radiation technique to treat brain metastases. It may help by aiming radiation tightly at the tumors while limiting exposure to nearby healthy brain.
This trial tests a new radiation therapy system called RayerKnife X to treat cancer that has spread to the brain. It aims to shrink the tumors with precise, high-dose radiation while reducing damage to healthy tissue, which may help control the disease and improve quality of life.
Hear when a new Brain Metastasases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.